Solubility Clause Samples

Solubility. When the appropriate volume of the recommended solvent is added, the fibrinogen must be soluble, and form a colourless solution. Identification
Solubility. The solubility class boundary is based on the highest dose strength of an IR product that is the subject of a biowaiver request. A drug substance is considered highly soluble when the highest dose strength is soluble in 250 ml or less of aqueous media over the pH range of 1–7.5. The volume estimate of 250 ml is derived from typical bioequivalence study protocols that prescribe administration of a drug product to fasting human volunteers with a glass (about 8 ounces) of water.
Solubility. In a previous study one of the major limitations in the iontophoretic transport of rotigotine.HCl was its low solubility. The maximum solubility of rotigotine.HCl was only 7.1 ± 0.4 mM at pH 5.0. In that study the iontophoretic transport at varying rotigotine.HCl concentrations between 1.4 and 3.9 mM showed a linear relationship between the Fluxss and the donor concentration [2]. This demonstrated that the maximum iontophoretic flux of rotigotine was not yet achieved, but the low solubility of rotigotine.HCl was the limiting factor for further increasing the iontophoretic flux. Higher donor concentrations could be achieved by replacing HCl by another salt [20-21]. As shown in Table 1, in the presence of 68 mM NaCl, the solubility of rotigotine increased substantially when HCl was replaced by H3PO4. Compared to rotigotine.HCl the solubility of rotigotine.H3PO4 is 2, 6, 10 fold higher at pH 6.0, 5.0 and 4.0, respectively. Furthermore in contrast to the solubility of the HCl-salt the presence of NaCl did not affect the solubility of rotigotine.H3PO4. This can be explained by an absence of the common ion effect. The next step was to investigate the transdermal delivery of rotigotine as H3PO4 salt.
Solubility. < [**] mg/mL in water; ³ [**] mg/mL in dimethylsulfoxide (DMSO); < [**] mg/mL in methanol

Related to Solubility

  • Geometric visibility The visibility of the illuminating surface, including its visibility in areas which do not appear to be illuminated in the direction of observation considered, shall be ensured within a divergent space defined by generating lines based on the perimeter of the illuminating surface and forming an angle of not less than 5° with the axis of reference of the headlamp.

  • Compatibility 1. Any unresolved issue arising from a mutual agreement procedure case otherwise within the scope of the arbitration process provided for in this Article and Articles 25A to 25G shall not be submitted to arbitration if the issue falls within the scope of a case with respect to which an arbitration panel or similar body has previously been set up in accordance with a bilateral or multilateral convention that provides for mandatory binding arbitration of unresolved issues arising from a mutual agreement procedure case. 2. Nothing in this Article and Articles 25A to 25G shall affect the fulfilment of wider obligations with respect to the arbitration of unresolved issues arising in the context of a mutual agreement procedure resulting from other conventions to which the Contracting States are or will become parties.”.

  • Quality All products will be new and unused. All products provided by the Contractor must meet all federal, state, and local standards for quality and safety requirements. Products not meeting the requirements of this section will be deemed unacceptable and returned to the Contractor for credit at no charge to the State.

  • Solution The Supplier’s contractually committed technical approach for solving an information technology business objective and associated Requirements as defined and authorized by the scope of the Contract or any order or Statement of Work issued under the Contract. Solution means all Supplier and Supplier’s third-party providers’ components making up the Solution, including but not limited to Software, Product, configuration design, implementation, Supplier-developed interfaces, Services and Work Product.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.